"Rethinking protein production: Why Pichia pastoris is gaining ground in biotech" by labiotech.eu
In a recent feature published by Labiotech, the expression host Pichia pastoris is highlighted as a high-performance alternative to traditional platforms such as E. coli and CHO cells.
At VALIDOGEN, with over 15 years of experience in tailored expression solutions, we share this vision and have leveraged our proprietary UNLOCK PICHIA® technology to enable high performance recombinnat protein production processes across biopharma, food/feed, and industrial biotech. The article underscores several key advantages:
Read the full Labiotech article “Rethinking protein production: Why Pichia pastoris is gaining ground in biotech” and explore how VALIDOGEN can support your project from protein expression feasibility to commercial-scale protein production.